Kelsi Dixon
Family · Estero, FLNPI 1427597145
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,301 of the $6,634 with a category attached, or 79.9%. It is spread thinly across 26 manufacturers, the largest accounting for just 23.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $2,669 and has fallen 83.5% since, to $440 in 2025. Among family clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 325 payments — averaging $20.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Johnson & Johnson$903
- Galderma Laboratories, L.p.$718
- Novartis$573
- Sun Pharmaceutical Industries Inc.$493
- Sanofi$445
- plus $2K from 20 others
What the payments were for
- Consulting fees$6009%
- Food & beverage$5,30180%
- Education$73311%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 93 | $1,524 |
| Johnson & Johnson | 62 | $903 |
| Galderma Laboratories, L.p. | 6 | $718 |
| Novartis | 39 | $573 |
| Sun Pharmaceutical Industries Inc. | 16 | $493 |
| Sanofi | 18 | $445 |
| Regeneron Healthcare Solutions, Inc. | 21 | $429 |
| Lilly USA, LLC | 15 | $373 |
| Pfizer | 12 | $227 |
| Amgen | 9 | $187 |
| Sanofi-aventis U.S. LLC | 2 | $130 |
| UCB, Inc. | 6 | $121 |
| Incyte Corporation | 3 | $65 |
| Dermavant Sciences, Inc. | 2 | $60 |
| Biofrontera Inc. | 4 | $58 |
| Organogenesis Inc. | 3 | $53 |
| LEO Pharma Inc. | 3 | $45 |
| Arcutis Biotherapeutics, Inc. | 2 | $42 |
| E.r. Squibb & Sons, L.L.C. | 2 | $40 |
| Organon | 1 | $32 |
| Almirall LLC | 1 | $25 |
| VYNE Pharmaceuticals Inc. | 1 | $20 |
| Mayne Pharma Commercial LLC | 1 | $20 |
| Paratek Pharmaceuticals, Inc. | 1 | $19 |
| Merz North America, Inc. | 1 | $17 |
| Sandoz | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,634 in reported general payments places this provider in the 95th percentile of 14,618 family providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 29 | $118,176 |
| Dupixent SyringeDupilumab | 15 | $66,194 |
| Fluorouracil | 84 | $5,667 |
| Clobetasol Propionate | 108 | $5,187 |
| Ketoconazole | 210 | $3,184 |
| Fluocinonide | 51 | $2,004 |
| Triamcinolone Acetonide | 157 | $1,125 |
| Betamethasone Dipropionate | 26 | $936 |
| Metronidazole | 13 | $853 |
| Ciclopirox | 26 | $626 |
| Hydrocortisone | 81 | $462 |
| Doxycycline Hyclate | 35 | $321 |
| Clindamycin Phosphate | 15 | $299 |
| ValacyclovirValacyclovir Hcl | 25 | $239 |
| Mupirocin | 27 | $198 |
Paid to pharmacies, not to this prescriber.
Other family in Estero
- Lewis HarringtonTampa$954K
- Danielle PharesFt Lauderdale$713K
- Donna OrtizOrlando$417K
- Patrick SzarazMiami$327K
- Deena RodneyMaitland$323K
- Yamila MelendezMiami$212K
- Holly BoydLand O Lakes$200K
- Rachael BuschLoxahatchee$189K
- Victor Tatis de la NuezMiramar$161K
- Ronda CrewsJax Bch$155K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.